|
ISSN: 1470-2045
Imprint: ELSEVIER
The Lancet Oncology is recognized for providing a global, authoritative and independent forum for the highest quality clinical
oncology research and opinion, covering all the key areas of oncology including breast, lung, colorectal and prostate cancers as well
as across all the major oncological disciplines ... click here for full Aims & Scope
The Lancet Oncology is recognized for providing a global, authoritative and independent forum for the highest quality clinical
oncology research and opinion, covering all the key areas of oncology including breast, lung, colorectal and prostate cancers as well
as across all the major oncological disciplines of chemotherapy, surgery, and radiotherapy.
The Lancet Oncology publishes
original research, reviews, personal views, commentaries, and news across the global field of oncology. The journal is stringently edited
and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked
to publication within weeks of submission and published first online on TheLancet.com before the print issue.
With an impact factor
of 17.76*, the journal ranks highly among the leading oncology journals which publish both original research and reviews.
Visit
 www.TheLancet.com to find out more about The Lancet Oncology.
* 2010 Journal Citation Reports, Thomson Reuters© 2011
Hide Aims & Scope
Editor: Contact the Editor
D. Collingridge PhD
|
|
